RE:RE:DM.V Institutional investors? You've hit the nail on the head. I understand that the government and NATO utilized AGPT during its R&D stages, backed by the $40M contract, even preceding the contract. However, from August 1st PR I understand that this contract is no longer active as AGPT has reached a level of maturity that places it outside the program’s parameters.
As articulated in the press release dated August 1st: “Current R&D project funding sources will need to be substituted with more advanced and extensive funding alternatives. The Canadian Government is steadfast in its commitment to the program and is resolved to see the project through to its completion.”
Had a new funding source been secured, it would have certainly been disclosed through a press release. DM would not hold that.
Consequently, we are looking at a situation where funding is no longer available, cash reserves are low, and there seems to be a stagnation or lack of information on other verticals, except for the clinics.
AGPT underwent a soft launch following a beta release. While it is prudent to ensure that the system is functional and scalable before proceeding with expansion, the reality is that AGPT remains elusive – much like Sasquatch. We all believe in its existence, but none of us have seen it in action or used it. I am confident that it does exist, but the absence of sales numbers and reviews raises questions and contribute strongly to the actual SP.
Addressing this is crucial to start making significant progress and moving the SP forward where I believe/hope it should be.
I don't think institutional investors are playing game with DM. They have better to do. Once AGPT will be the entire focus, alone in her shell (co) and it will be seen it will start generating value.
As I stated earlier I believe the timing for this is between now and mid December.